Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 1,721 Shares of Stock
MarketBeat
Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) insider Jonathan Zalevsky sold 1,721 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $33.52, for a total value of $57,687.92. Following the completion of the sale, the insider directly owned 17,462 shares of the company's stock, valued at $585,326.24. The trade was a 8.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
NASDAQ:NKTR